1-3 of 3
Tomas Jelinek
Close
Sort by
Journal Articles

Targeting CD38 by isatuximab and a CD38/CD3xCD28 trispecific T-cell engager in old patients with acute myeloid leukemia

Esperanza Martin-Sanchez, Laura Blanco Fernández, Peter S. Kim, Kamlesh Bisht, Hongfang Wang, Helgi Van de Velde, Tomas Jelinek, Catia Simoes, Felipe Prosper, Jesús F. San-Miguel, Ana Alfonso, Juan Miguel Bergua Burgues, Rebeca Rodríguez-Veiga, Susana Vives, David Martínez-Cuadrón, Pau Montesinos, Bruno Paiva, Aintzane Zabaleta
Journal: Blood Advances
Blood Adv bloodadvances.2024013212.
https://doi.org/10.1182/bloodadvances.2024013212
Published: 2024
Includes: Supplemental data
Journal Articles

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

Cirino Botta, Catarina Maia, Juan-José Garcés, Rosalinda Termini, Cristina Perez, Irene Manrique, Leire Burgos, Aintzane Zabaleta, Diego Alignani, Sarai Sarvide, Juana Merino, Noemi Puig, María-Teresa Cedena, Marco Rossi, Pierfrancesco Tassone, Massimo Gentile, Pierpaolo Correale, Ivan Borrello, Evangelos Terpos, Tomas Jelinek, Artur Paiva, Aldo Roccaro, Hartmut Goldschmidt, Hervé Avet-Loiseau, Laura Rosinol, Maria-Victoria Mateos, Joaquin Martinez-Lopez, Juan-José Lahuerta, Joan Bladé, Jesús F. San-Miguel, Bruno Paiva,
Journal: Blood Advances
Blood Adv (2022) 6 (2): 690–703.
https://doi.org/10.1182/bloodadvances.2021005198
Published: 2022
Includes: Supplemental data
Journal Articles

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine

Martina Zátopková, Tereza Ševčíková, Viola Fanfani, Zuzana Chyra, Lucie Říhová, Renata Bezděková, David Žihala, Kateřina Growková, Jana Filipová, Lucie Černá, Lucie Broskevičova, Fedor Kryukov, Jiří Minařík, Jana Smejkalová, Vladimír Maisnar, Ĺubica Harvanová, Luděk Pour, Alexandra Jungova, Tereza Popková, Juli Rodriguez Bago, Anjana Anilkumar Sithara, Matouš Hrdinka, Tomáš Jelínek, Michal Šimíček, Giovanni Stracquadanio, Roman Hájek
Journal: Blood Advances
Blood Adv (2022) 6 (2): 368–372.
https://doi.org/10.1182/bloodadvances.2020003876
Published: 2022
Includes: Supplemental data